Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-05

Clinical Trial Update: Impact of Weizmannia (Bacillus) Coagulans JBI-YZ6.3 on Gut Health and Fecal Microbiome Changes [NA]

View source ↗

Summary

A registered clinical trial is evaluating the probiotic Weizmannia coagulans JBI-YZ6.3 for effects on gut health and the fecal microbiome in people with gastroi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Weizmannia coagulans JBI-YZ6.3 (Weizmannia coagulans (strain JBI-YZ6.3))

Snippet

Sponsor: Lindenwood University | Conditions: Gastrointestinal Symptoms, Constipation | NA | Status: RECRUITING